Figure 1. Distribution of Age-Related Macular Degeneration Severity in the 3 Study Arms.
There was no significant difference in age-related macular degeneration presence or severity between intensive lifestyle (ILS), metformin, and placebo arms.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.